The Aesthetic Guide is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

FDA approves cosmetic tissue augmentation product

Article-FDA approves cosmetic tissue augmentation product

Washington — The Food and Drug Administration (FDA) has approved Anika Therapeutics Inc.’s cosmetic tissue augmentation (CTA) product, an injectable soft-tissue filler for facial wrinkles, scar remediation and lip augmentation.

The product is based on Anika’s chemically modified hyaluronic acid proprietary technology and incorporates lidocaine. In a statement, Woburn, Mass.-based Anika said it anticipates filing amendments with the FDA and European Union regulators to enhance product features prior to the launch of the CTA product, and added that the company anticipated marketing the enhanced version of its CTA product in mid-2007.

Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.